Overview Financials News + Filings Key Docs Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Consulting agrmnt
|
|
Pathfinder Cell Therapy, Inc. (PFND)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 04/05/2016 |
EFFECT
| Form EFFECT - Notice of Effectiveness |
| 03/30/2016 |
15-12G
| Form 15-12G - Securities registration termination [Section 12(g)] |
| 03/29/2016 |
8-K
| Form 8-K - Current report |
| 03/29/2016 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments |
| 03/29/2016 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments |
| 03/29/2016 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments |
| 03/29/2016 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments |
| 03/29/2016 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments |
| 03/29/2016 |
EFFECT
| Form EFFECT - Notice of Effectiveness |
| 03/29/2016 |
EFFECT
| Form EFFECT - Notice of Effectiveness |
| 03/16/2016 |
POS AM
| Form POS AM - Post-Effective amendments for registration statement |
| 03/16/2016 |
POS AM
| Form POS AM - Post-Effective amendments for registration statement |
| 11/13/2015 |
10-Q
| Quarterly Report for the period ended September 30, 2015 |
| 08/13/2015 |
10-Q
| Quarterly Report for the period ended June 30, 2015 |
| 05/15/2015 |
10-Q
| Quarterly Report for the period ended March 31, 2015 |
| 03/31/2015 |
10-K
| Annual Report for the period ended December 31, 2014 |
| 11/14/2014 |
10-Q
| Quarterly Report for the period ended September 30, 2014 |
| 08/14/2014 |
10-Q
| Quarterly Report for the period ended June 30, 2014 |
| 05/27/2014 |
10-K/A
| Annual Report for the period ended December 31, 2012 [amend] |
| 05/15/2014 |
10-Q
| Quarterly Report for the period ended March 31, 2014 |
| 04/30/2014 |
10-K/A
| Annual Report for the period ended December 31, 2013 [amend] |
| 03/31/2014 |
10-K
| Annual Report for the period ended December 31, 2013 |
| 03/31/2014 |
10-K/A
| Annual Report for the period ended December 31, 2012 [amend] |
| 11/14/2013 |
10-Q
| Quarterly Report for the period ended September 30, 2013 |
| 10/24/2013 |
8-K
| Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant, Unregister... |
| 08/14/2013 |
10-Q
| Quarterly Report for the period ended June 30, 2013 |
| 07/29/2013 |
8-K
| Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant, Unregister... |
| 05/29/2013 |
8-K
| Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant, Unregister... |
| 05/15/2013 |
10-Q
| Quarterly Report for the period ended March 31, 2013 |
| 04/30/2013 |
10-K/A
| Annual Report for the period ended December 31, 2012 [amend] |
| 04/29/2013 |
5
| Breisgau Bio Ventures S.A. (10% Owner) has filed a Form 5 on Pathfinder Cell Therapy, Inc. |
| 04/01/2013 |
10-K
| Annual Report for the period ended December 31, 2012 |
| 03/07/2013 |
8-K
| Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant, Unregister... |
| 03/06/2013 |
4
| Gruber Joerg (Chairman of the Board) has filed a Form 4 on Pathfinder Cell Therapy, Inc.|
Txns:
| Bought convertible notes
@ $100000, valued at
$0 |
|
|
|
|